Management of Left Atrial Myxoma
Surgical excision should be performed urgently as soon as the diagnosis is established, as this is the only definitive treatment and prevents life-threatening complications including stroke, sudden death, and acute cardiac obstruction. 1, 2
Immediate Management Priorities
All symptomatic left atrial myxomas require urgent surgical resection (Class I recommendation). 1 The urgency stems from three critical risks:
- Embolic complications: Myxomas carry a 25% overall embolism rate, with embolic stroke being the presenting symptom in up to 50% of cases 1, 3
- Mechanical obstruction: The tumor can cause sudden mitral valve obstruction during diastole, leading to syncope, acute heart failure, or sudden death 2, 4
- Unpredictable progression: Interstitial hemorrhage within the myxoma can cause rapid tumor expansion and acute decompensation 4
Diagnostic Workup
Echocardiography is the diagnostic modality of choice and sufficient to proceed to surgery without additional testing in most cases: 1, 3
- Transthoracic echocardiography (TTE) provides initial tumor visualization and assessment of hemodynamic impact 3
- Transesophageal echocardiography (TEE) offers superior sensitivity for tumor characterization, attachment site, and surgical planning 1, 3
- Cardiac MRI or CT may provide additional anatomic detail for complex cases but should not delay surgery 1, 3
Coronary angiography should be performed only in older patients at risk for coronary artery disease who may require concomitant coronary artery bypass grafting. 5
Surgical Approach
The surgical technique must include complete tumor excision with a wide margin of uninvolved atrial septum to prevent recurrence: 1, 5
- Median sternotomy with cardiopulmonary bypass is the standard approach 6
- Biatrial approach is preferred because it allows inspection of all four cardiac chambers, limits tumor manipulation (reducing embolic risk), and facilitates complete excision 5
- Excision of the tumor attachment site with adequate atrial septal margin is essential, as incomplete resection increases recurrence risk 1, 7
Surgical mortality is low (<1%) in experienced centers, and most patients have excellent long-term outcomes. 6, 5
Risk Stratification Based on Tumor Morphology
Myxomas with villous or papillary surface architecture have markedly higher embolic potential and require more urgent intervention: 1, 2
- Villous tumors have friable surfaces that generate thrombus and shed tumor fragments more readily 1
- Smooth-surface tumors carry lower embolic risk but still require prompt surgical excision 1
Critical Management Pitfalls to Avoid
Do NOT use anticoagulation or antiplatelet therapy alone as definitive treatment—these do not address mechanical obstruction and do not adequately prevent embolic complications. 1, 2
Do NOT perform pericardiocentesis if pericardial effusion is present, as this may worsen hemodynamics. 2
Do NOT delay surgery for extensive preoperative testing—echocardiographic diagnosis alone is sufficient to proceed. 5
Postoperative Follow-Up
Long-term clinical and echocardiographic surveillance is mandatory to monitor for recurrence: 1, 5, 7
- Recurrence occurs in 1-5% of sporadic cases and up to 10% in familial cases 1, 7
- Recurrence is most likely when initial resection was incomplete 7
- Follow-up echocardiography should be performed at regular intervals indefinitely 5, 7
Special Populations
For patients with right-sided cardiac tumors, evaluate for patent foramen ovale (PFO) because paradoxical embolism can occur. 3
Patients presenting with cryptogenic stroke should undergo TEE to identify left atrial myxoma as a potential embolic source. 1